Patent ID: 6048862
Filing Date: 2000-04-11
Classification: A61K,C07D

Abstract:
A method for treating a patient having a medical condition for which a 5-HT.sub.1D.alpha. receptor agonist is indicated, comprising the step of administering to the patient a pharmaceutical composition comprising a pharmaceutically acceptable carrier and, in an amount effective to stimulate the 5-HT.sub.1D.alpha. receptor, a compound selective for the 5-HT.sub.1D.alpha. receptor according to Formuia II: ##STR25## wherein R.sup.1 is selected from a group of Formula I and II: ##STR26## n is 1-3; R.sup.2 is selected from H and C.sub.1 -C.sub.6 alkyl;R.sup.3 is selected from H and C.sub.1 -C.sub.6 alkyl;R.sup.4 is selected from C.sub.1 -C.sub.6 alkyl, halo, phenyl, amino and nitro;R.sup.5 is selected from H, C.sub.1 -C.sub.6 alkyl and arylalkyl;R.sup.6 is selected from H or an alkylene group which is bonded to R.sup.4 to form the naphthalene ring skeleton; andsalts, hydrates and solvates thereof.